Steven Russell's most recent trade in Beta Bionics Inc. was a trade of 4,222 Common Stock done at an average price of $12.6 . Disclosure was reported to the exchange on June 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Beta Bionics Inc | Steven Russell | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 12.61 per share. | 02 Jun 2026 | 4,222 | 173,849 | - | 12.6 | 53,227 | Common Stock |
| Beta Bionics Inc | Steven Russell | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2026 | 109,105 | 180,122 | - | 0 | Common Stock | |
| Beta Bionics Inc | Steven Russell | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2026 | 91,520 | 91,520 | - | - | Employee Stock Option (right to buy) | |
| Beta Bionics Inc | Steven Russell | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2026 | 58,749 | 58,749 | - | - | Employee Stock Option (right to buy) | |
| Beta Bionics Inc | Steven Russell | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 12.36 per share. | 27 Feb 2026 | 1,026 | 179,096 | - | 12.4 | 12,683 | Common Stock |
| Beta Bionics Inc | Steven Russell | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 29.34 per share. | 02 Dec 2025 | 1,025 | 178,071 | - | 29.3 | 30,069 | Common Stock |
| Beta Bionics Inc | Steven Russell | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 18.86 per share. | 02 Sep 2025 | 1,015 | 71,017 | - | 18.9 | 19,146 | Common Stock |
| Beta Bionics Inc | Steven Russell | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 18.15 per share. | 02 Jun 2025 | 660 | 72,126 | - | 18.1 | 11,978 | Common Stock |
| Beta Bionics Inc | Steven Russell | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 17.03 per share. | 02 Jun 2025 | 285 | 72,786 | - | 17.0 | 4,853 | Common Stock |
| Beta Bionics Inc | Steven Russell | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 18.69 per share. | 02 Jun 2025 | 94 | 72,032 | - | 18.7 | 1,757 | Common Stock |
| Beta Bionics Inc | Steven Russell | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 52,000 | 52,000 | - | - | Employee Stock Option (right to buy) | |
| Beta Bionics Inc | Steven Russell | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 35,000 | 73,071 | - | 0 | Common Stock | |
| Beta Bionics Inc | Steven Russell | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 90,637 | 90,637 | - | - | Employee Stock Option (right to buy) | |
| Beta Bionics Inc | Steven Russell | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 81,217 | 81,217 | - | - | Employee Stock Option (right to buy) | |
| Beta Bionics Inc | Steven Russell | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 53,584 | 53,584 | - | - | Employee Stock Option (right to buy) | |
| Beta Bionics Inc | Steven Russell | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2025 | 90,637 | 90,637 | - | - | Employee Stock Option (right to buy) |